Hemab raised $157m Series C led by Sofinnova, joined by Avoro Capital, RA Capital, Novo, Access Biotechnology, Deep Track, HealthCap, Invus, Maj Invest Biotech Health services Investments 16 October 2025 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 157M Round investors: HealthCapNovo A/SSofinnova PartnersDeep Track CapitalAccess BiotechnologyMaj InvestRA Capital ManagementAvoro CapitalInvus Company: Hemab Industry: BiotechHealth services
ImCheck Therapeutics to be acquired by pharmaceutical company Ipsen for a total potential consideration up to €1 billion Biotech Health services Pharma M&A 12 October 2025
Tubulis raised €308 million in a Series C funding round co-led by Venrock, Wellington Management, and Ascenta Capital, Biotech Health services Investments 03 October 2025
Draig Therapeutics raised £107m with Access Biotechnology (led), SV Health Investors, ICG, Canaan Partners, SR One, Sanofi Ventures, and Schroders Capital. Biotech Health services Manufacturing Investments 07 June 2025
SpliceBio raised $135m in Series B co-led by EQT and Sanofi, w/ Roche Venture Fund, NEA, UCB Ventures, Ysios Capital, Gilde Healthcare, Novartis and Asabys. Biotech Health services Investments 01 June 2025